Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation

Liver International

Volumn 35, Issue 5, 2015, Pages 1590-1596

  Fernandez Ros, Nerea ^a   Iñarrairaegui, Mercedes ^a,b   Paramo, Jose A ^a   Berasain, Carmen ^b,c   Avila, Matias A ^b,c   Chopitea, Ana ^a   Varo, Nerea ^a   Sarobe, Pablo ^c   Bilbao, Jose I ^a   Dominguez, Ines ^a   D'Avola, Delia ^a,b   Herrero, J Ignacio ^a,b   Quiroga, Jorge ^a,b   Sangro, Bruno ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Centro para la Investigación Médica Aplicada   (Spain)

Author keywords

Endothelial injury; Inflammation; Liver hypertrophy; Liver regeneration; Liver tumours; Radioembolization induced liver disease

Indexed keywords

BILIRUBIN; BLOOD CLOTTING FACTOR 8; D DIMER; FIBROBLAST GROWTH FACTOR 19; INTERLEUKIN 6; INTERLEUKIN 8; MALONALDEHYDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SCATTER FACTOR; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER; CYTOKINE; MICROSPHERE;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BILIRUBIN BLOOD LEVEL; CANCER RADIOTHERAPY; CELL STRESS; CLINICAL ARTICLE; CLINICAL TRIAL; ENDOTHELIUM CELL; FEMALE; HEPATITIS; HUMAN; LIVER BLOOD FLOW; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER REGENERATION; MALE; OXIDATIVE STRESS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RADIOEMBOLIZATION; RADIOEMBOLIZATION INDUCED LIVER DISEASE; BLOOD; BLOOD CLOTTING; BLOOD FLOW; CARCINOMA, HEPATOCELLULAR; COHORT ANALYSIS; INFLAMMATION; LIVER; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; PROCEDURES; VASCULARIZATION;

AGED; BIOMARKERS; BLOOD COAGULATION; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; CYTOKINES; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; INFLAMMATION; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MICROSPHERES; MIDDLE AGED; OXIDATIVE STRESS; REGIONAL BLOOD FLOW;

EID: 84927693006     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12592     Document Type: Article

References (29)

1. Sangro B, Gil-Alzugaray B, Rodriguez J, et al. Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer 2008; 112: 1538-46.
2. Lawrence TS, Robertson JM, Anscher MS, et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1995; 31: 1237-48.
3. Shulman HM, Gown AM, Nugent DJ. Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules. Am J Pathol 1987; 127: 549-58.
4. Remberger M, Ringden O. Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver. Eur J Haematol 1997; 59: 254-62.
5. Lee JH, Lee KH, Kim S, et al. Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study. Bone Marrow Transplant 1998; 22: 883-8.
6. Scrobohaci ML, Drouet L, Monem-Mansi A, et al. Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers. Thromb Res 1991; 63: 509-19.
7. Tanikawa S, Mori S, Ohhashi K, et al. Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study. Bone Marrow Transplant 2000; 26: 881-6.
8. Gaba RC, Lewandowski RJ, Kulik LM, et al. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Ann Surg Oncol 2009; 16: 1587-96.
9. Jakobs TF, Saleem S, Atassi B, et al. Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres. Dig Dis Sci 2008; 53: 2556-63.
10. Seidensticker R, Seidensticker M, Damm R, et al. Hepatic toxicity after radioembolization of the liver using (90)Y-microspheres: sequential lobar versus whole liver approach. Cardiovasc Intervent Radiol 2012; 35: 1109-18.
11. Vouche M, Lewandowski RJ, Atassi R, et al. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol 2013; 59: 1029-36.
12. Ahmadzadehfar H, Meyer C, Ezziddin S, et al. Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre study. Eur J Nucl Med Mol Imaging 2013; 40: 80-90.
13. Edeline J, Lenoir L, Boudjema K, et al. Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting? Ann Surg Oncol 2013; 20: 2518-25.
14. Fernandez-Ros N, Silva N, Bilbao JI, et al. Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension. HPB (Oxford) 2014; 16: 243-9.
15. Yokoyama Y, Nagino M, Nimura Y. Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J Surg 2007; 31: 367-74.
16. Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 2010; 176: 2-13.
17. Kim RD, Kim JS, Watanabe G, Mohuczy D, Behrns KE. Liver regeneration and the atrophy-hypertrophy complex. Semin Intervent Radiol 2008; 25: 92-103.
18. Gil-Alzugaray B, Chopitea A, Inarrairaegui M, et al. Prognostic factors and prevention of radioembolization-induced liver disease. Hepatology 2013; 57: 1078-87.
19. Kim MJ, Jang JW, Oh BS, et al. Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma. Cytokine 2013; 64: 516-22.
20. Wickremesekera JK, Chen W, Cannan RJ, Stubbs RS. Serum proinflammatory cytokine response in patients with advanced liver tumors following selective internal radiation therapy (SIRT) with (90)Yttrium microspheres. Int J Radiat Oncol Biol Phys 2001; 49: 1015-21.
21. DeLeve LD, Wang X, Kuhlenkamp JF, Kaplowitz N. Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology 1996; 23: 589-99.
22. DeLeve LD, Wang X, Kanel GC, et al. Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. Hepatology 2003; 38: 900-8.
23. Fajardo LF, Colby TV. Pathogenesis of veno-occlusive liver disease after radiation. Arch Pathol Lab Med 1980; 104: 584-8.
24. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276: 60-6.
25. Uriarte I, Fernandez-Barrena MG, Monte MJ, et al. Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice. Gut 2013; 62: 899-910.
26. Kim TH, Mars WM, Stolz DB, Petersen BE, Michalopoulos GK. Extracellular matrix remodeling at the early stages of liver regeneration in the rat. Hepatology 1997; 26: 896-904.
27. Mohammed FF, Pennington CJ, Kassiri Z, et al. Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology 2005; 41: 857-67.
28. García-Irigoyen O, Carotti S, Latasa MU, et al. Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair. Liver Int. 2013. doi: 10.1111/liv.12337. [Epub ahead of print].
29. Yamazaki H, Oi H, Matsumoto K, et al. Biphasic changes in serum hepatocyte growth factor after transarterial chemoembolization therapy for hepatocellular carcinoma. Cytokine 1996; 8: 178-82.